Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H16N2.2ClH |
Molecular Weight | 249.18 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.C(N1CCNCC1)C2=CC=CC=C2
InChI
InChIKey=BBUJLUKPBBBXMU-UHFFFAOYSA-N
InChI=1S/C11H16N2.2ClH/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13;;/h1-5,12H,6-10H2;2*1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C11H16N2 |
Molecular Weight | 176.2581 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL238 Sources: https://doi.org/10.1080/03036758.2011.557036 |
|||
Target ID: CHEMBL2095159 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2448760 |
|||
Target ID: CHEMBL2095158 |
PubMed
Title | Date | PubMed |
---|---|---|
Acute psychosis following ingestion of 'Rapture'. | 2004 Dec |
|
Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS. | 2004 Feb |
|
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11. | 2005 Dec 15 |
|
Researching the toxicity of party pills. | 2005 Dec-2006 Jan |
|
Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector. | 2005 Mar |
|
Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats. | 2006 Apr |
|
Treatment of adolescent rats with 1-benzylpiperazine: a preliminary study of subsequent behavioral effects. | 2006 Jul-Aug |
|
Seizures in a night club. | 2007 Jul 21 |
|
MDMA-like behavioral effects of N-substituted piperazines in the mouse. | 2007 Nov |
|
Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand. | 2008 Nov |
|
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. | 2009 Apr |
|
Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants. | 2009 Apr 15 |
|
Party pills and drug-drug interactions. | 2009 Apr 24 |
|
Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents. | 2009 Feb |
|
Metabolic interactions with piperazine-based 'party pill' drugs. | 2009 Jul |
|
1-benzylpiperazine (BZP) abuse amongst attendees of the Drug Treatment Centre Board. | 2009 Jun |
|
Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation? | 2010 Jan |
|
Purchasing 'legal highs' on the Internet--is there consistency in what you get? | 2010 Jul |
|
New benzofuran derivatives as an antioxidant agent. | 2010 Mar |
|
Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high? | 2010 Mar |
|
Hydride transfer reactions via ion-neutral complex: fragmentation of protonated N-benzylpiperidines and protonated N-benzylpiperazines in mass spectrometry. | 2010 May |
|
Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples. | 2010 Oct |
|
A hybrid liquid chromatography-mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer. | 2010 Oct 29 |
|
Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol. | 2010 Sep |
|
Estrogenic effects and their action mechanism of the major active components of party pill drugs. | 2012 Nov 15 |
|
Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action. | 2015 Dec |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 12:18:18 GMT 2023
by
admin
on
Sat Dec 16 12:18:18 GMT 2023
|
Record UNII |
5CFGYMNN06
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
163993
Created by
admin on Sat Dec 16 12:18:18 GMT 2023 , Edited by admin on Sat Dec 16 12:18:18 GMT 2023
|
PRIMARY | |||
|
DTXSID20201294
Created by
admin on Sat Dec 16 12:18:18 GMT 2023 , Edited by admin on Sat Dec 16 12:18:18 GMT 2023
|
PRIMARY | |||
|
5CFGYMNN06
Created by
admin on Sat Dec 16 12:18:18 GMT 2023 , Edited by admin on Sat Dec 16 12:18:18 GMT 2023
|
PRIMARY | |||
|
12198046
Created by
admin on Sat Dec 16 12:18:18 GMT 2023 , Edited by admin on Sat Dec 16 12:18:18 GMT 2023
|
PRIMARY | |||
|
226-188-6
Created by
admin on Sat Dec 16 12:18:18 GMT 2023 , Edited by admin on Sat Dec 16 12:18:18 GMT 2023
|
PRIMARY | |||
|
5321-63-1
Created by
admin on Sat Dec 16 12:18:18 GMT 2023 , Edited by admin on Sat Dec 16 12:18:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |